Hwan Jung Yun Selected Research

Hwan Jung Yun Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 02/2009
8	Squamous Cell Carcinoma of Head and Neck 03/2024 - 03/2013
3	Stomach Neoplasms (Stomach Cancer) 05/2011 - 02/2009
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022 - 11/2016
2	Disease Progression 04/2019 - 12/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2019 - 12/2012
2	Diarrhea 03/2013 - 12/2012
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023
1	Febrile Neutropenia 10/2022
1	Infections 10/2022
1	Cancer Pain 01/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2019
1	Vomiting 01/2019
1	Nausea 01/2019
1	Hypertension (High Blood Pressure) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018
1	Fatigue 01/2018
1	Esophageal Neoplasms (Esophageal Cancer) 04/2017
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 02/2016
1	Nasopharyngeal Carcinoma 02/2016
1	Mucositis 01/2016
1	Esophageal Squamous Cell Carcinoma 12/2015
1	Astrocytoma (Pilocytic Astrocytoma) 12/2013
1	Oligodendroglioma 12/2013
1	Fever (Fevers) 03/2013
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 03/2013
1	Neutropenia 03/2013
1	Adenocarcinoma 12/2012
1	Dyspnea (Shortness of Breath) 12/2012
1	Carcinoma (Carcinomatosis) 09/2011
1	Prostatic Neoplasms (Prostate Cancer) 12/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2009
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 08/2008
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2007

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 04/2019 - 03/2013
4	PlatinumIBA 03/2024 - 12/2012
4	Biomarkers (Surrogate Marker)IBA 09/2023 - 02/2015
3	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 11/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 11/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 11/2016
3	dacomitinibIBA 01/2016 - 02/2015
2	Prednisone (Sone)FDA LinkGeneric 01/2023 - 11/2016
2	Rituximab (Mabthera)FDA Link 10/2022 - 11/2016
2	Tyrosine Kinase InhibitorsIBA 04/2019 - 02/2015
2	Pemetrexed (MTA)FDA Link 04/2019 - 12/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 12/2015
2	Proteins (Proteins, Gene)FDA Link 05/2011 - 02/2009
1	Immune Checkpoint InhibitorsIBA 03/2024
1	durvalumabIBA 03/2024
1	AnthracyclinesIBA 01/2023
1	pegfilgrastim (Neulasta)FDA Link 10/2022
1	Prednisolone (Predate)FDA LinkGeneric 10/2022
1	ErbB Receptors (EGF Receptor)IBA 04/2019
1	Methylprednisolone FDA LinkGeneric 03/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2019
1	Olanzapine (Zyprexa)FDA Link 01/2019
1	Palonosetron (Aloxi)FDA Link 01/2019
1	EnzymesIBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	pazopanib FDA Link 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	AntiemeticsIBA 12/2015
1	Temozolomide (Temodar)FDA LinkGeneric 12/2013
1	Docetaxel (Taxotere)FDA Link 03/2013
1	Gefitinib (Iressa)FDA Link 12/2012
1	CXCR ReceptorsIBA 05/2011
1	ChemokinesIBA 05/2011
1	CXCR4 Receptors (CXCR4 Receptor)IBA 05/2011
1	Phosphotransferases (Kinase)IBA 12/2009
1	Tyrosine (L-Tyrosine)FDA Link 12/2009
1	Sunitinib (Sutent)FDA Link 12/2009
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2009
1	Imatinib Mesylate (Gleevec)FDA Link 12/2009
1	Chemokine ReceptorsIBA 02/2009
1	Leucovorin (Folinic Acid)FDA Link 02/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2009
1	Fluorouracil (Carac)FDA LinkGeneric 02/2009

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2023 - 05/2007
6	Therapeutics 04/2019 - 12/2009
3	Radiotherapy 12/2017 - 01/2016
2	Induction Chemotherapy 01/2022 - 03/2013
2	Combination Drug Therapy (Combination Chemotherapy) 04/2017 - 02/2009
1	Stem Cell Transplantation 01/2023
1	Palliative Care (Palliative Therapy) 12/2020
1	Molecular Targeted Therapy 01/2019
1	Precision Medicine 01/2019
1	Chemoradiotherapy 09/2011
1	Cupping Therapy 08/2008